Depression
From the Journals
Single infusion of ketamine rapidly reduces suicidal thoughts
“This study identifies a second new domain of improvement – namely rapid improvement in several cognitive functions,” said Dr. J. John Mann.
From the Journals
Adding questions in primary care may help predict suicide risk
The researchers cited the urgency highlighted by statistics that show that, from 1999 to 2017, the U.S. suicide rate increased by more than 33%....
From the Journals
Do adolescents develop CNS autoimmunity after COVID-19?
The researchers examined three pediatric patients who were infected with SARS-CoV-2 and, over a period of 5 months in 2020, were admitted to the...
Commentary
Aaron Beck: An appreciation
Dr. Beck made cognitive restructuring come to life, said Dr. Nassir Ghaemi.
From the Journals
Newly discovered vascular barrier in the brain may explain IBD-related anxiety, depression
“This further supports my ongoing contention that the gut really is the center of the universe,” said Dr. David T. Rubin.
Latest News
Detransitioners received poor evaluation when transitioning
The reasons for detransitioning were varied, and many had more than one reason.
Feature
COVID-19 has brought more complex, longer office visits
Patients’ increased mental health needs and worsened chronic conditions have practices playing catch-up and expanding teams to ease demand.
Feature
Resident doctor who attempted suicide three times fights for change
“I often feel this sense of ... ‘you have to speak up, Justin; no one else can.’ ”
Latest News
Latest national suicide data released
There was concern that deaths due to suicide would increase in 2020, but this doesn’t appear to be the case.
Conference Coverage
FDA not recognizing efficacy of psychopharmacologic therapies
If this reorientation is going to lead to the broad indications the newer drugs likely deserve, “we have to move the FDA along,” said Dr. Stephen...
From the Journals
Antidepressant may cut COVID-19–related hospitalization, mortality: TOGETHER
In the latest study, fluvoxamine-treated patients had a 32% reduction in hospitalizations and emergency visits, compared with those in the placebo...